A Study to Evaluate the Metabolism and Excretion of [14C]-CC-90009 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 11, 2020

Primary Completion Date

June 4, 2021

Study Completion Date

June 4, 2021

Conditions

Healthy Volunteer

Interventions

DRUG

CC-90009

0.6 mg \[ 14C\]-CC-90009 administered IV as a single dose

RADIATION

[14C]

A single dose of \[ 14C\]-CC-90009 will contain approximately 2 µCi of radioactivity.

Trial Locations (1)

Covance Clinical Research Unit Inc., Madison